Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe Mounjaro shot is a once-weekly subcutaneous injection of tirzepatide, a dual GIP and GLP-1 receptor agonist licensed in the UK for weight management in adults with a BMI of 30 or above, or 27 or above alongside a weight-related health condition. Each pre-filled KwikPen delivers four weekly doses. The most common misconception is that the shot works simply by suppressing appetite — the reality is considerably more interesting, and understanding it helps set realistic expectations from the start. Mounjaro is a prescription-only medicine; a clinician assesses your suitability before it is prescribed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
People often assume the Mounjaro shot works the same way older diet medicines did, by blunting hunger through the brain. That's only part of the picture. Tirzepatide targets two separate gut-hormone pathways at once. The GLP-1 receptor slows how quickly food leaves the stomach and signals fullness to the brain; the GIP receptor works alongside it to influence fat metabolism and insulin sensitivity. No other weight-loss injection currently licensed in the UK activates both.
The practical upshot is that many people find their relationship with food shifts in ways that go beyond simply eating less. Cravings often reduce. The urgency around mealtimes settles. This matters when you're thinking about long-term change, because the mechanism supports the lifestyle adjustments that make results last, rather than fighting them.
Understanding the mechanism also clarifies why the titration schedule exists. Starting at 2.5 mg gives your digestive system time to adjust to slowed gastric emptying before the dose increases. Jumping straight to a higher strength wouldn't speed up results; it would mostly amplify side effects. The tirzepatide overview at nume covers the pharmacology in more detail if you'd like to read further.
The KwikPen is designed to be used at home without clinical training. Each pen contains four doses (one per week) so you use the same pen for an entire month before starting the next. Injection sites are the abdomen, the front of the thigh or the upper arm; rotating between them each week helps avoid skin reactions at any single spot. The guide to thigh injections is a good starting point if you're unsure which site suits you.
For the actual technique (how to hold the pen, what angle to use, how to check the dose window) the detailed walkthrough on how to give the Mounjaro shot covers every step. The Patient Information Leaflet that comes with your pen is also essential reading before your first injection; the specific instructions for your pen format take precedence over anything general you read online.
One timing question that comes up often is whether the day of the week matters. It doesn't, what matters is consistency. Pick a day that fits your routine and stick with it; the full reasoning is on the best time to take your Mounjaro shot page. If you're ever unsure whether you've missed a window or when to take a late dose, that's a question for your prescriber or the leaflet, not a forum.
According to the NHS tirzepatide medicines page, common side effects are mostly gastrointestinal: nausea, loose stools, constipation, burping and indigestion appear most often in the first weeks of a new dose. They tend to ease as your body settles. Staying well hydrated and eating smaller portions helps considerably.
The first injection is usually less daunting than people expect. The needle is fine and the pen mechanism is straightforward. What catches some people off guard is the timeline: week one often feels unremarkable. The 2.5 mg starting dose is there for tolerance, and most people don't notice dramatic appetite changes at that level. That isn't a sign that the medicine isn't working.
By weeks four to eight (once the dose has been reviewed and potentially increased) the appetite shift tends to become more noticeable. Meals feel satisfying sooner. Some people describe forgetting to eat, which sounds implausible until it happens. The Huel and Mounjaro page explores how some people structure nutrition around reduced appetite, which is a genuinely useful practical question.
Side effects, when they appear, are usually manageable. Nausea is the most reported; it's rarely severe enough to stop treatment, and eating slowly and avoiding fatty or rich foods makes a real difference. If you experience severe or persistent stomach pain that radiates to your back, seek medical attention promptly, the MHRA has highlighted acute pancreatitis as a known, though infrequent, risk with GLP-1 medicines, and early attention matters.
Cost is a practical consideration for most people starting private treatment. The context around Eli Lilly's UK price changes is worth reading before you budget, since the wholesale price changed significantly from September 2025 and private prices reflect that. What varies between providers is what that price actually includes.
Mounjaro is a prescription-only medicine. The only lawful route in the UK is a prescription issued by a qualified prescriber following a clinical assessment, not a purchase from a social-media seller or a website that offers it without one. Counterfeit pens have been seized in large quantities by the MHRA; some have contained the wrong medicine entirely. If a price looks dramatically lower than the market rate, that's worth treating as a warning sign rather than a bargain.
You can check whether any online pharmacy is properly registered using the GPhC pharmacy register. Legitimate services will always want to know your health history, verify your weight and ID, and have a prescriber review your information before issuing a prescription. That process exists for your safety, not as a bureaucratic inconvenience.
If you're ready to find out whether tirzepatide is clinically suitable for you, the process for getting the Mounjaro shot in the UK explains each step in plain terms. When you feel ready, start your free consultation, a GPhC-registered prescriber, not a piece of software, will review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.